EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study

Toshiyuki Imasawa, Chie Saito, Hirayasu Kai, Kunitoshi Iseki, Junichiro James Kazama, Yugo Shibagaki, Hitoshi Sugiyama, Daisuke Nagata, Ichiei Narita, Tomoya Nishino, Hajime Hasegawa, Hirokazu Honda und 12 weitere

Nephrology Dialysis Transplantation · 23.01.2023 · 38 (1) · 158-166

DOI: 10.1093/ndt/gfac041 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 23.02.2022. Verfasst von Toshiyuki Imasawa und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, National Hospital Organization Chiba-Higashi National Hospital, Nitonacho, Chuo-ku Chiba City, Chiba, Japan. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Practice facilitation program by multidisciplinary care for primary care physicians (PCPs) is expected to improve chronic kidney disease (CKD) outcomes, but there is no clear evidence of its long-term effectiveness. We have previously performed a cluster-randomized controlled trial for 3.5 years (the Frontier of Renal Outcome Modifications in Japan (FROM-J) study) with two arms—group A without the program and group B with the program. We aimed to assess the long-term effectiveness of the practice facilitation program on CKD outcomes via an extended 10-year follow-up of the FROM-J study.

Methods

We enrolled patients who were in the FROM-J study. The primary composite endpoint comprised cardiovascular disease (CVD), renal replacement therapy initiation and a 50% decrease in the estimated glomerular filtration rate (eGFR). The secondary endpoints were survival rate, eGFR decline rate and collaboration rate between PCPs and nephrologists.

Results

The occurrence of the primary composite endpoint tended to be lower in group B (group A: 27.1% versus group B: 22.1%, P = 0.051). Furthermore, CVD incidence was remarkably lower in group B (group A: 10.5% versus group B: 6.4%, P = 0.001). Although both mortality and the rate of eGFR decline were identical between both groups, the eGFR decline rate was significantly better in group B than in group A only in patients with stage G3a at enrollment (group A: 2.35 ± 3.87 mL/min/1.73 m2/year versus group B: 1.68 ± 2.98 mL/min/1.73 m2/year, P = 0.02). The collaboration rate was higher in group B.

Conclusions

The CKD practice facilitation program for PCPs reliably decreases CVD events and may reduce the progression of cases to end-stage kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicCardiovascular DiseasesHumansFollow-Up StudiesJapanKidneyGlomerular Filtration RatePrimary Health CareDisease Progression

Stichwörter der Autor:innen

cardiovascular disease eventchronic kidney diseasemultidisciplinary carepractice facilitation programprimary care physicians

Autor:innen und Institutionen

  • Department of Nephrology, National Hospital Organization Chiba-Higashi National Hospital, Nitonacho, Chuo-ku Chiba City, Chiba, Japan.
  • Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tennodai, Tsukuba, Ibaraki, Japan.
  • Okinawa Heart and Renal Association (OHRA), Aja, Naha, Okinawa, Japan.
  • Department of Nephrology and Hypertension, Fukushima Medical University, Hikariga-oka, Fukushima, Japan.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, St Marianna University School of Medicine, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan.
  • Department of Human Resource Development of Dialysis Therapy for Kidney Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho, Kita-ku, Okayama, Japan.

ORCID-Profile: Mariko Miyazaki, Takashi Wada

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Imasawa, T., Saito, C., Kai, H., Iseki, K., Kazama, J. J., Shibagaki, Y., Sugiyama, H., Nagata, D., Narita, I., Nishino, T., Hasegawa, H., Honda, H., Maruyama, S., Miyazaki, M., Mukoyama, M., Yasuda, H., Wada, T., Ishikawa, Y., Tsunoda, R., …, & Yamagata, K. (2023). Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study. Nephrology Dialysis Transplantation, 38(1), 158-166. https://doi.org/10.1093/ndt/gfac041

Vancouver

Imasawa T, Saito C, Kai H, Iseki K, Kazama JJ, Shibagaki Y, et al. Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study. Nephrology Dialysis Transplantation. 2023;38(1):158-166. doi:10.1093/ndt/gfac041

BibTeX
@article{Imasawa2023,
  author = {Imasawa, Toshiyuki and Saito, Chie and Kai, Hirayasu and Iseki, Kunitoshi and Kazama, Junichiro James and Shibagaki, Yugo and Sugiyama, Hitoshi and Nagata, Daisuke and Narita, Ichiei and Nishino, Tomoya and Hasegawa, Hajime and Honda, Hirokazu and Maruyama, Shoichi and Miyazaki, Mariko and Mukoyama, Masashi and Yasuda, Hideo and Wada, Takashi and Ishikawa, Yuichi and Tsunoda, Ryoya and Nagai, Kei and Okubo, Reiko and Kondo, Masahide and Hoshino, Junichi and Yamagata, Kunihiro},
  title = {Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {1},
  pages = {158--166},
  doi = {10.1093/ndt/gfac041}
}
Kostenlos starten →